Abstract
An oral contraceptive combining quinestrol and quingestanol acetate was administered on a once-a-month program, and its effects on plasma lipids and lipoproteins were studied. Significant increases in triglyceride (+32 per cent) and phospholipids (+16 per cent) were noted, but the average plasma cholesterol levels did not change. The average increases were qualitatively similar to those previously reported with the more traditionally administered contraceptives but were of lesser magnitude.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
